A kimerizmus immunpatológiai és klinikai jelento{double acute}sége csontvelo{double acute}-transzplantációban és szervátültetésekben

Barta Anikó, Lengyel Lilla, Sipos Andrea, Torbágyi Éva, Földi János, Páldi Haris Piroska, Tamáska Júlia, Gyódi Éva, K. Rajczy, Hoffer Izabella, Jakab Judit, Kormos Luca, G. Petrányi, K. Pálóczi

Research output: Contribution to journalArticle

Abstract

Chimerism is an exceptional immunogenetic state, characterized by the survival and collaboration of cell populations originated from two different individuals. The prerequisites to induce chimerism are immunosuppression, myeloablation or severe immunodeficiency of the recipients on one side and donor originated immuno-hematopoietic cells in the graft on the other. Special immunogenetic conditions to establish chimerism are combined with bone marrow transplantation, transfusion and various kinds of solid organ grafting. There are various methods to detect the type of chimera state depending on the immunogenetic differences between the donor and recipient. The chimera state seems to be one of the leading factors to influence the course of the post-transplant period, the frequency and severity of graft-versus-host disease (GVHD), and the rate of relapse. However, the most important contribution of the chimeric state is the development of graft versus leukemia (GVL) effect. A new conditioning protocol (DBM/Ara-C/Cy) for allogeneic BMT in CML patients and its consequence on chimera state and GVL effect is demonstrated.

Original languageHungarian
Pages (from-to)15-21
Number of pages7
JournalMagyar Onkologia
Volume45
Issue number1
Publication statusPublished - 2001

ASJC Scopus subject areas

  • Oncology

Cite this

A kimerizmus immunpatológiai és klinikai jelento{double acute}sége csontvelo{double acute}-transzplantációban és szervátültetésekben. / Anikó, Barta; Lilla, Lengyel; Andrea, Sipos; Éva, Torbágyi; János, Földi; Piroska, Páldi Haris; Júlia, Tamáska; Éva, Gyódi; Rajczy, K.; Izabella, Hoffer; Judit, Jakab; Luca, Kormos; Petrányi, G.; Pálóczi, K.

In: Magyar Onkologia, Vol. 45, No. 1, 2001, p. 15-21.

Research output: Contribution to journalArticle

Anikó, B, Lilla, L, Andrea, S, Éva, T, János, F, Piroska, PH, Júlia, T, Éva, G, Rajczy, K, Izabella, H, Judit, J, Luca, K, Petrányi, G & Pálóczi, K 2001, 'A kimerizmus immunpatológiai és klinikai jelento{double acute}sége csontvelo{double acute}-transzplantációban és szervátültetésekben', Magyar Onkologia, vol. 45, no. 1, pp. 15-21.
Anikó, Barta ; Lilla, Lengyel ; Andrea, Sipos ; Éva, Torbágyi ; János, Földi ; Piroska, Páldi Haris ; Júlia, Tamáska ; Éva, Gyódi ; Rajczy, K. ; Izabella, Hoffer ; Judit, Jakab ; Luca, Kormos ; Petrányi, G. ; Pálóczi, K. / A kimerizmus immunpatológiai és klinikai jelento{double acute}sége csontvelo{double acute}-transzplantációban és szervátültetésekben. In: Magyar Onkologia. 2001 ; Vol. 45, No. 1. pp. 15-21.
@article{d8538ecf014244af872db0632c9394d3,
title = "A kimerizmus immunpatol{\'o}giai {\'e}s klinikai jelento{double acute}s{\'e}ge csontvelo{double acute}-transzplant{\'a}ci{\'o}ban {\'e}s szerv{\'a}t{\"u}ltet{\'e}sekben",
abstract = "Chimerism is an exceptional immunogenetic state, characterized by the survival and collaboration of cell populations originated from two different individuals. The prerequisites to induce chimerism are immunosuppression, myeloablation or severe immunodeficiency of the recipients on one side and donor originated immuno-hematopoietic cells in the graft on the other. Special immunogenetic conditions to establish chimerism are combined with bone marrow transplantation, transfusion and various kinds of solid organ grafting. There are various methods to detect the type of chimera state depending on the immunogenetic differences between the donor and recipient. The chimera state seems to be one of the leading factors to influence the course of the post-transplant period, the frequency and severity of graft-versus-host disease (GVHD), and the rate of relapse. However, the most important contribution of the chimeric state is the development of graft versus leukemia (GVL) effect. A new conditioning protocol (DBM/Ara-C/Cy) for allogeneic BMT in CML patients and its consequence on chimera state and GVL effect is demonstrated.",
author = "Barta Anik{\'o} and Lengyel Lilla and Sipos Andrea and Torb{\'a}gyi {\'E}va and F{\"o}ldi J{\'a}nos and Piroska, {P{\'a}ldi Haris} and Tam{\'a}ska J{\'u}lia and Gy{\'o}di {\'E}va and K. Rajczy and Hoffer Izabella and Jakab Judit and Kormos Luca and G. Petr{\'a}nyi and K. P{\'a}l{\'o}czi",
year = "2001",
language = "Hungarian",
volume = "45",
pages = "15--21",
journal = "Magyar Onkologia",
issn = "0025-0244",
publisher = "Akademiai Kiado",
number = "1",

}

TY - JOUR

T1 - A kimerizmus immunpatológiai és klinikai jelento{double acute}sége csontvelo{double acute}-transzplantációban és szervátültetésekben

AU - Anikó, Barta

AU - Lilla, Lengyel

AU - Andrea, Sipos

AU - Éva, Torbágyi

AU - János, Földi

AU - Piroska, Páldi Haris

AU - Júlia, Tamáska

AU - Éva, Gyódi

AU - Rajczy, K.

AU - Izabella, Hoffer

AU - Judit, Jakab

AU - Luca, Kormos

AU - Petrányi, G.

AU - Pálóczi, K.

PY - 2001

Y1 - 2001

N2 - Chimerism is an exceptional immunogenetic state, characterized by the survival and collaboration of cell populations originated from two different individuals. The prerequisites to induce chimerism are immunosuppression, myeloablation or severe immunodeficiency of the recipients on one side and donor originated immuno-hematopoietic cells in the graft on the other. Special immunogenetic conditions to establish chimerism are combined with bone marrow transplantation, transfusion and various kinds of solid organ grafting. There are various methods to detect the type of chimera state depending on the immunogenetic differences between the donor and recipient. The chimera state seems to be one of the leading factors to influence the course of the post-transplant period, the frequency and severity of graft-versus-host disease (GVHD), and the rate of relapse. However, the most important contribution of the chimeric state is the development of graft versus leukemia (GVL) effect. A new conditioning protocol (DBM/Ara-C/Cy) for allogeneic BMT in CML patients and its consequence on chimera state and GVL effect is demonstrated.

AB - Chimerism is an exceptional immunogenetic state, characterized by the survival and collaboration of cell populations originated from two different individuals. The prerequisites to induce chimerism are immunosuppression, myeloablation or severe immunodeficiency of the recipients on one side and donor originated immuno-hematopoietic cells in the graft on the other. Special immunogenetic conditions to establish chimerism are combined with bone marrow transplantation, transfusion and various kinds of solid organ grafting. There are various methods to detect the type of chimera state depending on the immunogenetic differences between the donor and recipient. The chimera state seems to be one of the leading factors to influence the course of the post-transplant period, the frequency and severity of graft-versus-host disease (GVHD), and the rate of relapse. However, the most important contribution of the chimeric state is the development of graft versus leukemia (GVL) effect. A new conditioning protocol (DBM/Ara-C/Cy) for allogeneic BMT in CML patients and its consequence on chimera state and GVL effect is demonstrated.

UR - http://www.scopus.com/inward/record.url?scp=84874965181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874965181&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84874965181

VL - 45

SP - 15

EP - 21

JO - Magyar Onkologia

JF - Magyar Onkologia

SN - 0025-0244

IS - 1

ER -